Back |
home / stock / bcda / bcda message board
Subject | By | Source | When |
---|---|---|---|
Trial due dates from last year's 10K | realfast95 | investorshub | 03/07/2019 5:40:08 PM |
BioCardia and CellProThera Partner for Clinical Trial and | subslover | investorshub | 10/30/2018 4:19:51 PM |
Biotech billionaire Phillip Frost charged by SEC, sending | XenaLives | investorshub | 09/09/2018 10:33:14 AM |
so stat sig in 6MWD and NYHA and | JPeets22 | investorshub | 08/22/2018 9:03:42 PM |
it appears so. But I'm not a doctor. | realfast95 | investorshub | 08/22/2018 6:29:14 PM |
$BCDA top-line Phase III data out. Looks good | JPeets22 | investorshub | 08/22/2018 5:42:20 PM |
5% Stockholders: | realfast95 | investorshub | 07/20/2018 3:09:23 PM |
Honestly if you are invested in this stock, | ZorbaTheGreek27 | investorshub | 12/30/2017 4:04:12 AM |
JUST A MATTER OF TIME BEFORE $BCDA IS | Bona Vista | investorshub | 12/29/2017 3:13:44 PM |
It does appear that Frost was scammed on | realfast95 | investorshub | 12/02/2017 11:06:54 PM |
IS THAT GOING TO MAKE THE PRICE MOVE | Bona Vista | investorshub | 12/01/2017 1:29:13 PM |
Emylers: CDOM Financials 07/16/2014 18:46:32 Tiger X Medical, Inc. Period Ending Dec 31, 2013 Dec 31 | Emylers | investorshangout | 07/16/2014 11:46:28 PM |
chartguy89: CDOM 0.081 Stock Charts $CDOM 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 1:37:30 PM |
chartguy89: CDOM Stock Charts Monday, February 24, 2014 at 8:25:09 AM $CDOM Last: UNCH | chartguy89 | investorshangout | 02/24/2014 1:25:21 PM |
News, Short Squeeze, Breakout and More Instantly...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the confirmatory Phase 3 trial of its autologous CardiAMP cell therap...
SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Unites States Patent Office has granted Patent No: 12,036,371 ti...
SUNNYVALE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the Unites States Patent Office has granted Patent No: ...